Cetera Advisor Networks’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$49.6K Buy
15,177
+583
+4% +$1.92K ﹤0.01% 2743
2023
Q4
$51.2K Sell
14,594
-582
-4% -$1.8K ﹤0.01% 2705
2023
Q3
$101K Sell
15,176
-1,873
-11% -$13.9K ﹤0.01% 2562
2023
Q2
$143K Buy
17,049
+2,641
+18% +$26K ﹤0.01% 2412
2023
Q1
$143K Hold
14,408
﹤0.01% 2391
2022
Q4
$100K Sell
14,408
-7,018
-33% -$40.1K ﹤0.01% 2382
2022
Q3
$114K Hold
21,426
﹤0.01% 1944
2022
Q2
$85K Hold
21,426
﹤0.01% 1970
2022
Q1
$95K Hold
21,426
﹤0.01% 1971
2021
Q4
$86K Buy
+21,426
New +$163K ﹤0.01% 1974
2021
Q2
Sell
-11,188
Closed -$133K 1897
2021
Q1
$133K Hold
11,188
﹤0.01% 1418
2020
Q4
$77K Hold
11,188
﹤0.01% 1321
2020
Q3
$83K Buy
+11,188
New +$72.3K ﹤0.01% 1211

Other funds holding ALDX

Cetera Advisor Networks's ALDX Position: Q1 2024 in Review

Cetera Advisor Networks increased its Aldeyra Therapeutics (ALDX) stake by 4% in Q1 2024, buying an estimated $1.92K and bringing the position to 15,177 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Cetera Advisor Networks first reported a position in ALDX in Q3 2020 and has held it in 13 quarters since. The position peaked at $143K in Q1 2023. 102 funds tracked by Wall St. Rank hold ALDX as of Q1 2024.

  • Cetera Advisor Networks held 15,177 shares of Aldeyra Therapeutics worth $49.6K as of Q1 2024.
  • Cetera Advisor Networks bought 583 Aldeyra Therapeutics shares in Q1 2024, an estimated $1.92K.
  • Aldeyra Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2743 holding.
  • Cetera Advisor Networks first reported a position in Aldeyra Therapeutics in Q3 2020 and has held it in 13 quarters since.
  • Cetera Advisor Networks's Aldeyra Therapeutics position peaked at $143K in Q1 2023.
  • 102 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.